Does INTERFERON BETA Cause Hepatocellular carcinoma? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatocellular carcinoma have been filed in association with INTERFERON BETA. This represents 1.9% of all adverse event reports for INTERFERON BETA.
5
Reports of Hepatocellular carcinoma with INTERFERON BETA
1.9%
of all INTERFERON BETA reports
1
Deaths
1
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From INTERFERON BETA?
Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does INTERFERON BETA Cause?
Off label use (95)
Eosinophilia (46)
Pruritus (30)
Rash maculo-papular (27)
Drug ineffective (26)
Multiple sclerosis relapse (26)
Rash (24)
Dizziness (23)
Pyrexia (21)
Ataxia (15)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which INTERFERON BETA Alternatives Have Lower Hepatocellular carcinoma Risk?
INTERFERON BETA vs INTERFERON BETA-1A
INTERFERON BETA vs INTERFERON BETA-1B
INTERFERON BETA vs INTERFERON GAMMA
INTERFERON BETA vs INTERFERON GAMMA-1B
INTERFERON BETA vs INVEGA